Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes-Reference-Cited by-同舟云学术

Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes

Published:1984-07 Issue:1 Volume:35 Page:19-25
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Almér Lars-Olof

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. On fibrinolysis in diabetes mellitus;Almér;Acta Med. Scand.,1975

2. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy;Pandolfi;Acta Ophthal.,1974

3. Diabetic retinopathy and the fibrinolytic system;Almér;Diabetes,1975

4. Effect of the sulphonylureas on fibrinolysis;Fearnley;Lancet,1960

5. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties: Protective activity of S 1702 on the microvascular system in normal and diabetic rats;Duhault;Arzneimittelforsch. (Drug Res.),1972

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2015-07-29

2. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2013-04-30

3. Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies;Archivum Immunologiae et Therapiae Experimentalis;2009-11-03

4. Narusheniya v sisteme gemostaza pri sakharnom diabete i puti ikh korrektsii pri naznachenii kombinirovannoy terapii Diabetonom MV i metforminom;Diabetes mellitus;2007-09-15

5. Platelet abnormalities in diabetes mellitus;Coronary Artery Disease;2003-08